Go to the list of all blogs
Anna G's Avatar
published in Blogs
Feb 28, 2025
πŸ“ˆ "Walgreens Boots Alliance ($WBA) Shines: A Stellar Weekly Gain of +5.06%" πŸš€

πŸ“ˆ "Walgreens Boots Alliance ($WBA) Shines: A Stellar Weekly Gain of +5.06%" πŸš€

This week, Walgreens Boots Alliance (WBA, $22.42) has been the talk of the town in the trading community, showcasing an impressive rise of +5.06%. Out of the 26 drugstore chains analyzed, WBA was among the top performers, aligning itself with the 50% of stocks in the industry that experienced an uptrend.

🌟 Unlock the Potential of Trading with Walgreens Boots Alliance (WBA) Using AI! πŸ€–πŸ“ˆ

Walgreens Boots Alliance (WBA) has made headlines with its stellar weekly gain of +5.06%. If you're looking to capitalize on such opportunities, our AI trading tools are here to assist.

πŸ“‰ "Swing Trader for Beginners: Trading in Markets Trending Down (TA&FA)" provides insights into trading in downward trending markets, helping you make informed decisions during market declines.

πŸš€ "Swing Trader: High Capitalization (TA)" focuses on high-cap stocks, potentially allowing you to optimize your trading strategy within the high-cap sector, where WBA operates.

With AI precision and insights, you can fine-tune your WBA trading strategy, reduce risks, and make data-driven decisions. Seize opportunities and embark on your journey to trading success with AI expertise! πŸ“ŠπŸ“‰πŸŒŸ Discover the future of trading with AI-powered insights! πŸ’ΌπŸ€–

Earnings Insights πŸ“Š:

The earnings report unveiled on June 27 exhibited an EPS of $1.00, which fell short of the anticipated $1.08. Holding a strong 7.70M shares outstanding, WBA's current market cap is pegged at a solid $19.35 billion.

Dividend Alert πŸ’°:

WBA shareholders were rewarded with a dividend payout of $0.48 per share, having a record date set for September 12, 2023. Those considering jumping into WBA stocks should note the ex-dividend date of August 18, 2023.

Industry Bigwigs πŸ”:

In the Drugstore Chains arena, a few names dominate the scene with Walgreens Boots Alliance and Rite Aid Corp being the most prominent ones.

Industry Snapshot 🌐:

The drugstore chains industry is a cornerstone in the retail sector. Encompassing the sale of both prescription and non-prescription medications, as well as health and personal care products, this industry has shown resilience against economic downturns. Furthermore, some major chains have evolved to offer pharmacy benefits management services. Giants like CVS Health Corporation, alongside WBA, steer this ship, making the industry a mainstay in the market.

Market Capitalization Landscape πŸ™οΈ:

Delving deeper into the market cap of the Drugstore Chains, the average stands at $2.96 billion. WBA comfortably sits atop this list with a valuation of $19.35 billion, while RLLVF ranks at the bottom with a mere $3.29K.

Price Dynamics 🎒:

The weekly price movement in the industry remained static at 0%. However, the monthly and quarterly figures painted a gloomier picture, with dips of -9% and -2% respectively. While Rite Aid Corp made waves with a 21% spike, HEWA faced a slump, dropping by -20%.

Volume Play πŸ“‰:

The week saw an average volume dip of -3% across the industry. When analyzed on a broader scale, monthly volumes plummeted by -66%, but there was a silver lining with quarterly volumes rising by 49%.

Analyzing the Fundamentals πŸ“š:

  • Valuation Rating: 58
  • P/E Growth Rating: 74
  • Price Growth Rating: 63
  • SMR Rating: 76
  • Profit Risk Rating: 91
  • Seasonality Score: 22

WBA's Trading Recap πŸ”„: Over the past five trading sessions, WBA witnessed a gain of +5.50%, attracting an average daily volume of 913,236 shares. However, the stock faced a drawdown of -4.39% during this timeframe. WBA's earnings announcement on June 26, 2023, added to the overall market buzz.

As the trading week wrapped up, Walgreens Boots Alliance (WBA) emerged as a beacon for traders and investors in the Drugstore Chains Industry. Here's to more such bullish weeks! πŸ“ˆπŸ₯‚

AI Patterns 1
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.